Posted by Gary Schwitzer in Conflicts of interest, Drug industry, Health care journalism
NPR’s “On the Media” program this weekend looked at drug industry influence on media messages, including an interview with Senator Charles Grassley about his investigations of the industry.
The program also featured an interview with me about our HealthNewsReview.org project and about other issues involving health care news sources’ conflicts of interest.
Comments are closed.
Treatment for advanced ovarian tumors may lengthen survival, but questions still remain, despite the story’s emphasis on “promising” and “new hope.”
As with the HealthDay story on this research that we reviewed, readers of this story get a good dose of caveats and cautions along with the suggestions that electrical brain stimulation might someday “have implications” for treatment of Alzheimer’s disease.
The readers of this story and the other one we reviewed by Reuters are likely to understand that electrical brain stimulation could have some memory effects, but it’s a long way from becoming a treatment for Alzheimer’s disease.
We will not display your name or e-mail address on the site, nor will we share youre-mail address with any third parties.
For site updates and news from Gary, find us on Twitter:
HealthNewsReview: @HealthNewsRevu
Gary Schwitzer: @garyschwitzer
Copyright © 2012 Health News Review
